Worth up to $2.4 billion, the acquisition is also the latest in a series of buyouts involving startups with technologies that modify immune cells inside the body.

Hybridization between domestic animals and wildlife is a growing concern worldwide, particularly as feral pigs and wild boar increasingly overlap. A ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced Bionano Symposium 2026, the premier global event for the optical genome mapping (OGM) community. This virtual symposium provides a unique platform ...

Antibiotic resistance (AR) has steadily accelerated in recent years to become a global health crisis. As deadly bacteria evolve new ways to elude drug treatments for a variety of illnesses, a growing ...

On February 2, Wave Life Sciences Ltd. (NASDAQ:WVE) said it regained full rights to WVE-006, a potential treatment for ...

Researchers at Texas A&M are pairing a widely used ingredient with advanced medical technology to develop new treatments for ...

Convicted sex offender Jeffrey Epstein paid for genetic testing in an apparent bid to harness his own genetic material for regenerative medicine – which is aimed at repairing the body by developing ...

A million years of kitchen accidents may have forced the human immune system to evolve.

With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ...

A multi-institutional study led by researchers at UNC Lineberger Comprehensive Cancer Center, the Salk Institute for Biological Studies, and UC San Diego has uncovered new genetic rules that determine ...

The ACMG Foundation for Genetic and Genomic Medicine (ACMGF) is pleased to announce that Bo Yuan, PhD, FACMG, has been selected as the recipient of the 2026 Dr. Michael S. Watson Genetic and Genomic ...